Home/ Supplements/ Iron/ OncoMAR

OncoMAR

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 36% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula provides protein, iron, magnesium, and zinc to support basic nutritional needs and cellular function. There is strong evidence that these minerals and macronutrients are essential for metabolic health and immune support. However, the overall evidence coverage for this specific ingredient profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for OncoMAR
Open Full PDF View on NIH DSLD →
Details

Label Data

8 Capsule(s)
Serving Size
30
Servings
Botanical
Product Type
36%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 {Calories}
Protein
3 Gram(s) (6% DV)
Iron
1 ng (6% DV)
54 mg (14% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
2 mg (13% DV)
Within RDA (0.2× RDA) 263 studies (A:6, B:134)
0.1 mg (5% DV)
Within RDA (0.1× RDA) 37 studies (A:0, B:11)
3 mg (150% DV)
1.3× RDA — within safe limits 9 studies — no high-quality reviews
7 mcg (6% DV)
Within RDA (0.2× RDA) 199 studies (A:1, B:55)
26 mcg (35% DV)
Within RDA (0.6× RDA) 3 studies — no high-quality reviews
Potassium
170 mg (5% DV)
Avemar freeze-dried fermented Wheat Germ 47:1 extract
5.5 Gram(s)

Other Ingredients

HPMC Stearic Acid Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take one 8-capsule packet of OncoMAR(TM) per day. Best absorbed on an empty stomach, 1 hour before or after food. Consume 2 hours before or after taking any drugs or other dietary supplements.

Warnings & Precautions

Consult your healthcare practitioner prior to use. Do not use if tamper seal is damaged.

This formula should not be taken during pregnancy or while nursing.

Consult with a healthcare professional for recommended usage level for children, and for guidance on using more than 1 OncoMAR packet per day.

Do not consume OncoMAR(TM) if you have had an organ or tissue transplant, or if you are hypersensitive to wheat or yeast.

This product is not intended to be the sole source of nutrients in the diet.

STORAGE: Store in a cool dry place, 41-79(0)F (5-26(0)C), out of reach of children.

Contains: Wheat, gluten, and yeast.

Formulation Notes

Each packet of 8 OncoMAR(TM) capsules contains 5.5g Avemar(R) fermented wheat germ actives, without maltodextrin.

Improvements include utilizing low temperature freeze-drying, which eliminates the need to use maltodextrin as a stabilizer, and removing the sweetener and flavoring.

As a result, OncoMAR contains 99% less stabilizing and flavoring additives, while maintaining the same quality of Avemar fermented wheat germ actives as used in clinical trials.

Each packet of 8 OncoMAR(TM) capsules contains 5.5g Avemar(R) fermented wheat germ actives, without maltodextrin.

Does not contain: Corn, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.

Patented Avemar(R) Fermented Wheat Germ Freeze-Dried Extract Standardized to Methoxy-Substituted Benzoquinones

Contains: Wheat, gluten, and yeast.

Additional Information

Professional use only

The labeling on this product does not comply with California's Proposition 65. Therefore, this product may not be sold in California.

The development of Avemar fermented wheat germ extract has become the life’s work of Dr. Hidvegi. He was inspired to build upon the theories and experiments of Hungarian Nobel Prize winner, Dr. Albert Szent-Gyorgyi. Dr. Hidvegi’s patented processes yield a consistency effective standardized extract that has been extensively researched. Avemar has been the subject of over 100 studies in cell lines, with animals and clinical trials, reported in more than 30 articles in medical peer-reviewed journals.

Improving on his original patented, fermented wheat germ-processing method, he has now created OncoMAR in vegetarian capsule form – so this unique dietary supplement is easier than ever to take on a daily basis.

Subjects in clinical trials consumed 8.5g per day of Avemar pulvis, consisting of 5.5g Avemar fermented wheat germ actives with 3g maltodextrin, a non-active stabilizer.

STORAGE: Store in a cool dry place, 41-79(0)F (5-26(0)C), out of reach of children.

ePV:

ePV

Exclusive professional formulas

VEGETARIAN CAPS

THIRD-PARTY VERIFIED GMP COMPLIANT

Scan to learn more! {QRC}

ZLB-ONCOCAP-02 REV. 021115

This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00262 6
DSLD Entry Date2015-08-25
Product TypeBotanical
FormCapsule
BrandXYMOGEN
DSLD ID49803
Data Updated2026-04-11
Research

Research Evidence

566
Research Sources
56
Avg Quality
240
Meta Analysis
100
Clinical Trial
74
Systematic Review
71
Guideline
58
Rct
11
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
1
Observational
1
Openfda Safety
A Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency
Meta Analysis Nature medicine 2025 PubMed DOI
A Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Serum or plasma ferritin concentration as an index of iron deficiency and overload
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Non-invasive diagnostic tests for Helicobacter pylori infection
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
A Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Fortification of condiments and seasonings with iron for preventing anaemia and improving health
Meta Analysis The Cochrane database of systematic reviews 2023 PubMed DOI
A Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2024 PubMed DOI
A Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis and systematic review
Meta Analysis Neuroscience and biobehavioral reviews 2025 PubMed DOI
View all evidence for Iron →
Compare

Similar Products

View all Iron products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.